S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
NYSE:MDT

Medtronic - MDT Competitors

$82.58
+0.74 (+0.90%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$80.81
$83.17
50-Day Range
$76.13
$82.58
52-Week Range
$75.76
$114.31
Volume
4.86 million shs
Average Volume
6.30 million shs
Market Capitalization
$109.85 billion
P/E Ratio
25.65
Dividend Yield
3.29%
Price Target
$94.25

MDT vs. GILD, ELV, SYK, SNY, ISRG, VRTX, REGN, AMGN, ZTS, and MRNA

Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Gilead Sciences (GILD), Elevance Health (ELV), Stryker (SYK), Sanofi (SNY), Intuitive Surgical (ISRG), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Amgen (AMGN), Zoetis (ZTS), and Moderna (MRNA). These companies are all part of the "medical" sector.

Medtronic vs.

Gilead Sciences (NASDAQ:GILD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Gilead Sciences has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500.

Medtronic has a net margin of 14.03% compared to Gilead Sciences' net margin of 12.29%. Gilead Sciences' return on equity of 38.51% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Gilead Sciences 12.29% 38.51% 12.35%
Medtronic 14.03% 13.52% 7.77%

Gilead Sciences has higher earnings, but lower revenue than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Gilead Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gilead Sciences$27.31 billion3.85$6.23 billion$2.6531.60
Medtronic$31.69 billion3.47$5.04 billion$3.2225.65

Gilead Sciences received 868 more outperform votes than Medtronic when rated by MarketBeat users. Likewise, 78.07% of users gave Gilead Sciences an outperform vote while only 77.22% of users gave Medtronic an outperform vote.

CompanyUnderperformOutperform
Gilead SciencesOutperform Votes
2431
78.07%
Underperform Votes
683
21.93%
MedtronicOutperform Votes
1563
77.22%
Underperform Votes
461
22.78%

Gilead Sciences presently has a consensus target price of $87.40, indicating a potential upside of 4.38%. Medtronic has a consensus target price of $94.25, indicating a potential upside of 14.13%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than Gilead Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gilead Sciences
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
Medtronic
1 Sell rating(s)
14 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.20

78.7% of Gilead Sciences shares are owned by institutional investors. Comparatively, 80.4% of Medtronic shares are owned by institutional investors. 0.2% of Gilead Sciences shares are owned by company insiders. Comparatively, 0.3% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Gilead Sciences pays an annual dividend of $2.92 per share and has a dividend yield of 3.5%. Medtronic pays an annual dividend of $2.72 per share and has a dividend yield of 3.3%. Gilead Sciences pays out 110.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Medtronic pays out 84.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Gilead Sciences has raised its dividend for 7 consecutive years and Medtronic has raised its dividend for 46 consecutive years.

In the previous week, Gilead Sciences had 18 more articles in the media than Medtronic. MarketBeat recorded 24 mentions for Gilead Sciences and 6 mentions for Medtronic. Gilead Sciences' average media sentiment score of 0.65 beat Medtronic's score of -0.20 indicating that Gilead Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Gilead Sciences
5 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Medtronic
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Gilead Sciences beats Medtronic on 12 of the 21 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDT vs. The Competition

MetricMedtronicElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$109.85B$3.51B$4.56B$14.59B
Dividend Yield3.29%1.63%2.21%3.40%
P/E Ratio25.658.9694.6018.94
Price / Sales3.4743.073,617.7420.25
Price / Cash10.8528.5023.9828.37
Price / Book2.103.616.365.09
Net Income$5.04B$133.34M$164.78M$902.96M
7 Day Performance2.06%-0.21%5.61%38.02%
1 Month Performance6.13%8.46%28.66%48.53%
1 Year Performance-19.93%27.91%-5.32%-3.99%

Medtronic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GILD
Gilead Sciences
2.7541 of 5 stars
$84.07
+0.1%
$87.45
+4.0%
+21.6%$105.44B$27.31B31.7214,400Upcoming Earnings
Analyst Report
Short Interest ↓
Analyst Revision
News Coverage
ELV
Elevance Health
2.994 of 5 stars
$495.59
+3.6%
$578.89
+16.8%
+11.4%$118.94B$138.64B19.4498,200Earnings Report
Dividend Increase
Analyst Report
Analyst Revision
News Coverage
SYK
Stryker
2.6519 of 5 stars
$252.95
-1.1%
$260.68
+3.1%
+2.3%$95.72B$17.11B39.3446,000Upcoming Earnings
Analyst Report
Analyst Revision
News Coverage
SNY
Sanofi
2.4832 of 5 stars
$48.89
+0.7%
$102.88
+110.4%
-8.1%$123.93B$44.68B17.7195,442Upcoming Earnings
ISRG
Intuitive Surgical
2.9604 of 5 stars
$243.80
-5.5%
$278.95
+14.4%
-9.0%$86.16B$5.71B64.339,793Earnings Report
Analyst Report
Analyst Revision
News Coverage
High Trading Volume
VRTX
Vertex Pharmaceuticals
2.5257 of 5 stars
$315.28
+0.5%
$316.00
+0.2%
+32.3%$80.93B$7.57B24.863,900Analyst Report
Insider Selling
Analyst Revision
News Coverage
REGN
Regeneron Pharmaceuticals
2.1793 of 5 stars
$741.18
+1.9%
$785.90
+6.0%
+18.9%$80.72B$16.07B15.6310,368Upcoming Earnings
Analyst Report
Analyst Revision
News Coverage
AMGN
Amgen
2.8356 of 5 stars
$256.54
-1.2%
$253.57
-1.2%
+10.7%$136.88B$25.98B20.5724,200Upcoming Earnings
Analyst Downgrade
Analyst Revision
News Coverage
ZTS
Zoetis
2.5805 of 5 stars
$165.51
-0.2%
$215.17
+30.0%
-15.4%$77.14B$7.78B37.7912,100
MRNA
Moderna
2.4583 of 5 stars
$193.07
-1.9%
$191.62
-0.8%
+18.7%$74.17B$18.47B6.992,700Analyst Report
Insider Selling
Analyst Revision
This page (NYSE:MDT) was last updated on 1/29/2023 by MarketBeat.com Staff